Abstract We describe the outcome since 1984 of all children receiving chronic dialysis in our centre for >3 months with a minimum follow-up of 5 (median 7.2) years. There were 98 children (61 boys), with a median age at the start of dialysis of 4.2 (range: birth to 16.2) years. Twenty-one children started dialysis at <1 year of age and 54 under <5 years. Thirty children had significant comorbidity. The median time on dialysis was 1.4 (0.3 to 14.4) years, giving a total dialysis experience of 296 patient-years. Fifty-three children received a renal transplant as their first change of treatment modality, but 31 switched between PD and HD, with a total of 54 changes of dialysis modality pre-transplantation. Twenty-one of the transplanted patients (39%) returned to dialysis. There were a total of 115 transplants in 88 patients. There was a positive increase for both the weight and height SDS for all the age groups while on dialysis, but this did not reach statistical significance. There were 17 deaths over the 20-year study period; of these, 10 died on dialysis. The overall patient survival was 83%. The mortality rate was 2.7 times greater in children who required renal replacement therapy under the age of 5 years. Of the deaths, 76% were in association with comorbid conditions. In conclusion, both a younger age at the start of renal replacement therapy and comorbidity are significant risk factors for death. The number of returnees to dialysis highlights the importance of conserving dialysis access.
Introduction
Children have been offered dialysis treatment for the last 30 years and comprise approximately 2% of any national dialysis programme [1] . Despite this, long-term outcome data for this group are scarce, reflecting the relatively small numbers involved and the difficulties in tracking these patients beyond adolescence [2] . While successful transplantation is now an achievable goal even for the very young, many will return to dialysis during the course of their end-stage renal disease (ESRD) management, and some will require long-term dialysis.
Outcome data from large registries such as the USRDS (United States Renal Data System) [1] , UK Renal Registry (United Kingdom Renal Registry) [2] , ANZDATA (Australia and New Zealand Dialysis and Transplant Registry) [3] , the Dutch Registry [4] and NAPRTCS (North American Pediatric Renal Transplant Cooperative Study) [5] are available. However, they do not give information on important factors that influence outcome such as comorbidity, developmental outcome and longterm longitudinal growth. Using follow-up over 20 years, we have been able to describe such long-term outcome data, and also details of other factors that may influence outcome that have not previously been published in such a large group of children with ESRF, such as parathyroid hormone (PTH) control and the number of transitions between dialysis and transplantation. Our results highlight the significantly increased risk of death in young children with comorbidity and the continuous cycling of patients between dialysis and transplant.
!3 months), with a minimum follow-up of 5 years. It should be noted that Great Ormond Street Children's Hospital is a tertiary referral centre for nephro-urological problems and hence receives a proportionately higher number of children with multiple problems, both multisystemic and genetic.
Patients
Between January 1984 and December 1998, 98 children (61 boys) received chronic peritoneal or haemodialysis at Great Ormond Street Hospital for Children. The primary diagnoses were as follows: renal dysplasia (32), posterior urethral valves (17) , congenital nephrotic syndrome (12) , focal segmental glomerulosclerosis (9), bilateral Wilm's tumour (4), cystinosis (4), cortical necrosis (3), Alport's syndrome (3), nephronophthisis (3), autosomal recessive polycystic kidney disease, post-streptococcal acute glomerulonephritis, atypical haemolytic uraemic syndrome and glomerulosclerosis in 2 cases each, nephrocalcinosis of unknown etiology in 1 case and metabolic disorders with end-stage renal involvement (methylmalonicacidaemia and Lesch-Nyhan syndrome) in 1 case each.
Methods
We undertook a retrospective review of the notes to collect the following information: (1) demographic data: diagnosis, associated comorbid factors and age at the start of renal replacement therapy (RRT); (2) details of the dialysis regimen used: index course of dialysis, switches between dialysis modalities, duration of dialysis therapy before transplantation and return to dialysis after a failed transplant; (3) outcome measures on dialysis: the anthropometric data, parathormone (PTH) levels and developmental outcome have been reviewed in all children.
Changes in standard deviation scores (SDS) for weight and height for the duration of dialysis treatment have been described using the SDS at the initiation of dialysis as a baseline with final scores calculated at the time of transplant or at final follow-up. Changes in height SDS have been calculated only for those children who received dialysis for !6 months (n=78). The developmental progress of all the children was determined as part of the pretransplant work-up using the Griffith's Mental Development Test or the Bayley's Infant Development Scores (in the 1 year olds). (4) All children have been followed-up for a minimum period of 5 years from the initiation of dialysis with final follow-up up to 31 December 2003. Details regarding the current dialysis modality or transplantation after transfer to adult units were obtained through telephonic queries. Mortality data, including the cause of death and any association with comorbidity, were reviewed.
Statistics
Statistical analysis for growth variables (expressed as mean and standard deviations) was performed in all children, comparing values at the start of dialysis treatment with the final levels (measured at the time of renal transplantation or last follow-up) using the paired t test. Statistical significance was defined as P <0.05. Kaplan-Meyer survival analysis was performed for the entire cohort as well as for those starting dialysis under the age of 5 years.
Results

Incidence
Ninety-eight children received chronic peritoneal or haemodialysis at Great Ormond Street Children's Hospital between January 1984 and December 1998, i.e., an average of 5.7 new patients required RRT each year. With the merging of children's renal services in 1996 there was an expansion of the dialysis programme, with 45 new cases requiring dialysis between January 1996 and December 1998: 11.2 new patients per year.
Comorbidity
Significant comorbidity, including multi-organ involvement with cardiac, gastrointestinal and metabolic disorders, was present in 30 children before starting dialysis. Fifteen children had moderate to severe learning difficulties with special education needs. Five infants were born prematurely at 32 weeks gestation; one of these had learning difficulties with infantile hemiplegia. None of the premature babies had pulmonary hypoplasia. An antenatal diagnosis of obstructive uropathy was made in 28 fetuses. In a contemporaneous study from this institution [14] , 13 of 101 infants died following withdrawal of treatment: only 2 of these children had been started on dialysis before withdrawal of treatment (Table 1) . All the patients from group 1 and those marked with * from group 2 had special educational needs
Age at start of renal replacement therapy
The median age at the start of dialysis was 4.2 (range, birth to 16.2) years, with the youngest patients starting PD and HD from day 1 and day 16 of life, respectively. Twenty-one children were under 1 year, and 33 were between 1-5 years of age. Thus, 54% of the patients were in the under-5 age group. There were 61 males, with a male:female ratio of 1.6:1.
Index modality of dialysis
As shown in Figure 1 , of the 98 patient cohort, 80 received PD as the initial modality of dialysis. APD (automated peritoneal dialysis) was the preferred method with CAPD (continuous ambulatory peritoneal dialysis) used only rarely and for short periods (e.g., during holidays, or to accommodate lifestyle changes in teenagers). Thus, the ratio of PD to HD was 4.4:1. PD was clearly the preferred modality of renal replacement therapy in the younger age groups-only 3 of the 21 children (14.3%) under 1 year of age who required dialysis were started on HD, and 9 of the 54 under 5 years (16.6%) started HD as the initial modality of dialysis. In these children PD was not considered appropriate due to co-existing problems: acute or chronic renal failure with life-threatening complications demanding immediate dialysis (n=3), following bilateral nephrectomies (n=2), while awaiting maturation of the PD access (n=2), recent abdominal surgery (n=1) and social concerns precluding PD (n=1) (Fig. 1) .
Switches between dialysis modalities
There were a total of 54 switches between dialysis modalities with a maximum of 5 switches in one patient. HD was principally used as a backup for PD in most cases, with HD used only transiently in the majority. The reasons for changing to HD were peritonitis [bacterial peritonitis that was resistant to antibiotic treatment or fungal peritonitis (23)], a 'rest' from PD following intraabdominal surgery (6), leakage or non-function of the Tenchkoff catheter (18) or peritoneal membrane failure (7) . Of this group, 41 children received HD for 3 months before returning to PD (39) or receiving a transplant (2) .
The median duration on PD before peritoneal membrane failure (defined as inadequate ultrafiltration with or without peritoneal adhesions and decreased peritoneal surface area) was 3.9 (1.9-7.3) years. The child who remained on PD for 7.3 years was highly sensitised after two failed transplants and remained on HD for a further 1.7 years before receiving his third transplant. The remainder of the PD patients did not wait significantly longer prior to transplantation.
One child returned to conservative management after 18 months on PD. He had posterior urethral valves with dysplastic kidneys, but only mild renal insufficiency until he developed mesangiocapillary glomerulonephritis at age 9.7 years when he required dialysis. He remains in stable chronic renal failure (with hypertension and proteinuria) at follow-up (6.8 years after discontinuing dialysis).
Total time on dialysis
The median time on dialysis was 1.4 (0.3-14.4) years, giving the centre a total dialysis experience of 296 patient-years. The median time spent on PD was 1.7 (0.4-14.4) years, while the median time on HD was 0.7 (0.3-4.1) years.
Transplantation
Of the 98 children, 88 (90%) received a renal transplant, 29 (33%) live related. This includes ten patients who had received a pre-emptive transplant, but had returned to dialysis following graft failure, while the remaining 78 received a period on dialysis pre-transplantation. Ten (11%) children received a transplant after transfer to an adult unit; further details have not been included in this 
Returnees to dialysis
Twenty-one of the 68 transplanted patients (31%) returned to dialysis. The median transplant survival was 10.1 (0.1-18+) years: 14.8 (0.1-18+) years for a liverelated transplant and 7.2 (0.1-18+) years with a cadaveric transplant. In total there were 115 transplants in 88 children, with 19 receiving their second grafts and 4 their third grafts before transfer to an adult unit.
Outcome measures on dialysis
Growth
The changes in median weight and height SDS [SDS at the start of dialysis treatment-final SDS (measured at the time of renal transplantation or final follow-up)] are shown in Fig. 2 . The median weight SDS was -2.8 (1.0 to -4.2) at the start of dialysis and -1.7 (3.6 to -4.0) pretransplant or at the final follow-up (P =0.06; Fig. 2 ). The median height SDS (n=78) improved from -2.8 (1.9 to -5.0) at the start of dialysis to -1.9 (range 0.8 to -4.8). The height deficit was most severe in the youngest patients: in children starting dialysis at <5 years of age, the baseline height SDS was -3.6 (1.1 to -5.0), with a final height SDS of -2.6 (0.2 to -4.2) (P=0.078). The change from baseline in height deficit (DZ-score) was 0.5 (0.9 to -1.1) for the overall population. When calculated for those children 
PTH
Intact parathyroid hormone assay (PTH) was performed serially in 91 children (available from April 1989). As the PTH assay has changed during the study period, the levels have been expressed as within twice the upper limit of the normal range (ULN). The measured intact PTH level at the start of dialysis was less than twice the ULN in 15 (16%) children as compared to a considerably improved control with 80 (88%) children having a PTH level within twice the upper limit of normal at final follow-up or pretransplantation. PTH levels were better controlled in the children who predominantly received PD than in the group who were on haemodialysis for the majority of their renal replacement therapy: 58 of the 69 (84%) of the PD population had a PTH level within twice the ULN at the final follow-up or pre-transplantation, while 15 of the 22 (70%) on haemodialysis achieved PTH levels within twice the ULN.
Development
Of the 30 children with comorbidity, 15 had special educational needs. None of the children without comorbidity had learning difficulties and all were in age-appropriate mainstream education.
Mortality
There were 17 deaths over the study period ( Table 2 ). The overall patient survival was 92% at 1 year, 88% at 5 years and 84% at 10 years from the index dialysis treatment. Ten deaths (59%) occurred on dialysis (seven on PD) and seven following transplant. Six (35%) patients had never been transplanted. The median age at death was 5.9 (0.8-18.6) years. Six (35%) of these children had started dialysis before their first birthday, and 13 of the 17 (76%) started dialysis before the age of 5 years (Fig. 3) . In those children starting dialysis at 1 year of age, the 5-year survival was 72% as compared to patients above 1 year of age at the start of dialysis, when the relative risk of death was 2. There were 13 deaths in the 5-year age group: a 2.7 times higher relative risk of death than in those starting dialysis above 5 years of age.
Thirteen of the 17 (76%) children who died had nonrenal comorbidity. Comorbidity was identified as a sig- nificant risk factor for poor prognosis-there was a 7.5 times greater risk of death in this group. Table 2 describes the causes of death and associations with comorbidity, age at the start of dialysis and age at transplant. Overall, there was no significant difference in mortality depending on the year of starting dialysis, with seven deaths in the group starting dialysis before 1990 (n=33) compared to ten deaths after 1990.
Follow-up
The median follow-up time was 7.2 (5-18.6) years from the initiation of dialysis. One patient returned to his native country following transplantation and has been lost to follow-up. During this study period, 27 patients were transferred to adult units. Following transfer, ten received renal transplants. One patient died soon after transfer. At final follow-up, the overall survival was 83%. Of the survivors, 68 (84%) have a functioning graft, 11 (14%) remain on dialysis, 1 patient is conservatively managed and 1 has been lost to follow-up.
Discussion
This single-centre 20-year longitudinal outcome study is the largest and longest follow-up non-registry study of dialysis patients 5 years of age. It demonstrates three important points: a younger age at the start of renal replacement therapy and comorbidity are important predictors of poor outcome and the high number of returnees to dialysis highlights the importance of conserving dialysis access. Despite the improved survival of children and adolescents with end-stage renal disease, there are few long-term outcome data available. Longitudinal outcome studies on large numbers of patients are required to allow informed decision making by clinicians and the involved families. The UK Renal Registry (6th annual report, 2003) [2] has 6 years of continuous data collection from the 13 paediatric renal units in the UK and gives detailed information on patient demographics, causes of ESRD, growth and mortality data. The Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry [3] and the Dutch Registry [4] offer long-term survival data and demonstrate an improvement in survival based on the time of starting RRT. The largest available database comes from the North American Pediatric Renal Transplant Co-operative Study (NAPRTCS) involving 134 centres from North America. Its recent 2003 annual report [5] offers extensive demographic, anthropometric and mortality data. We have compared our results with the above registry reports and the pan-European ERA-EDTA Registry [6] . Our study offers a longer period of longitudinal follow-up and growth data and associations with comorbidity that are not found in any of the above registries. Treatment thresholds vary amongst different centres, reflecting the varying opinions amongst nephrologists [7, 8, 9] towards offering RRT to the very young or those with comorbidity. The median age at the start of RRT was lower in our cohort than in the other registries-54% were younger than 5 years of age (with 21% 1 year) at the initiation of dialysis. This is in contrast to 22.9% of the under 5 year-olds in the NAPRTCS report [5] and 9.3% in the ANZDATA Registry [3] . In both of these registries the majority of children starting RRT were in the older teenage years-38% in the NAPRTCS 2003 report [5] and 51% in ANZDATA [3] . The significantly greater number of very young children in our study is likely to have influenced our growth and mortality data.
Conserving dialysis access is of vital importance in the young patient with ESRD in whom RRT is necessarily a life-long undertaking. In our patient group there were 54 switches between dialysis modalities pre-transplantation, with 21 patients returning to dialysis after a failed trans- Fig. 3 Long-term survival in the study group plant. In the NAPRTCS 2001 annual report [10] 66% of all dialysis episodes were terminated, 24% of these were due to a change in dialysis modality, with approximately 50% of dialysis courses terminating within 12 months of initiation. Although 38% of our patients changed dialysis modality during the study period, this is over a considerably longer follow-up period than in the NAPRTCS 2001 report. The National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) [11] and the U.K. Renal Association standards document [12] , although largely based on adult practice, offer recommendations on optimal dialysis access and its preservation.
Although statistical significance was not reached, there was a trend towards improvement in weight and height SDS while on dialysis. Also, children with comorbidity have been included in the analysis, keeping in mind that they will negatively influence the statistics. As shown in other registry reports [2, 5] , most of the children with poor linear growth presented in the 1st year of life. This study spans 20-years of data and includes patients starting dialysis in the mid-1980s when most series showed deterioration in height SDS on dialysis and when aggressive nutritional management was not pursued. However, as shown in more recent reports [4, 9, 12] and in infant dialysis series from our hospital [13, 14, 15] , increase in height on both PD and HD can take place on dialysis. Although impressive growth rates with the use of growth hormone (rhGH) in infants have been reported in many studies, in this institution we have shown that the change in height SDS is matched by a rigorous feeding programme in children under 2.5 years age [16, 17, 18] . In older children on dialysis, rhGH has a less dramatic effect [19] , with the maximum benefit seen in pre-terminal renal failure [20] and an improvement in height SDS with only the 1st year of treatment [21] .
As demonstrated in several registry reports, a younger age at the start of RRT is a strong predictor of mortality [2, 3, 4, 5] . Despite the overall younger age of our study group, the mortality was two times greater in children who started RRT at 1 year of age than in those at !1 year; the 5-year survival was 72% in this group. This compares favourably with the UK Renal Registry report wherein the 5-year survival rate for children starting RRT at 1 year of age was 66% (92% 5-year survival for the whole population) [2] . NAPRTCS reports a 66% 3-year survival [5] and ANZDATA a 73% 5-year survival [3] in children 1 year of age (the overall population survival rates were 89% at 3 years and 86% at 5 years in the two series, respectively). Also, ANZDATA has shown a fourfold higher mortality in the 1 year olds as compared to patients between 15-19 years of age at the initiation of dialysis [3] . A selection bias reflecting the ethical views of the referral centres or the nephrologists may well have resulted in the apparent differences in outcome of the 1 s starting RRT. Early transplantation, especially preemptive transplantation, has been shown to improve survival and reduce mortality in young children <5 years of age with ESRF [22] . Unfortunately, there was limited statistical power in this study to enable determination of the relative risk of death between the two modalities of dialysis or any association between the duration of dialysis pre-transplantation and overall survival.
While no single most common cause of death could be identified in our study, NAPRTCS, ANZDATA and the Dutch cohort studies [23] report 'cardiac/cardiopulmonary' as the most common cause of death [24] . NAPRTCS reports that 21.8% of all deaths were from cardiopulmonary causes, both for the overall population and for each age group [5] , ANZDATA reports that 43% of deaths in the PD group and 57% in the HD group were from cardiac causes [3] , and the Dutch cohort [4] reports cardiac deaths in 33% of the children who received RRT for >10 years. In our study there was only one death from a cardiac cause (congestive cardiac failure): this child had received dialysis for 1.3 years and had two failed grafts.
In our cohort non-renal comorbidity was a significant predictor of poor outcome with a 7.5 times increased risk of death. The comorbid factors seen in our children were part of a syndrome complex with multisystem involvement. Comorbidity has not been discussed in any registry data, but some other series have shown an association between comorbidity and increased mortality rates [25, 26] . Many of these reports principally discuss pulmonary and renal comorbid factors (e.g., anuria), but as this study includes children who had received dialysis for a minimum period of 3 months, infants with life-limiting pulmonary disease are necessarily excluded. This study does not have sufficient statistical power to describe comorbidity as a risk factor independent of age.
In conclusion, our data show that both a younger age at initiation of dialysis and comorbidity are significant risk factors for poor outcome. The number of returnees to dialysis highlights the importance of conserving dialysis access.
